Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹1,355.20
Market cap: ₹6,241 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 49.4×Sector 50.4×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Sep 2026 13:42 IST BSE

Business Update

Senores Pharmaceuticals Business Update

Senores Pharma's subsidiary Apnar Pharma completed a USFDA inspection at its Vadodara facility with no GMP observations. Only one minor procedural finding was noted.

Read the filing ↗